Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$12.89 -10.0%	$11.04	$8.27 ▼ $30.10	$429.45M	1.31	683,065 shs	625,013 shs
CNXU Conexeu Sciences	$15.24 -4.8%	$0.00	$10.87 ▼ $18.79	$385.12M	N/A	103,889 shs	35,394 shs
FONR Fonar	$19.09	$18.83	$13.62 ▼ $19.16	$117.79M	0.95	140,673 shs	N/A
KIDS OrthoPediatrics	$18.32 +1.2%	$16.89	$14.42 ▼ $23.70	$464.90M	1.03	141,467 shs	83,242 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	+7.67%	+16.99%	+29.01%	+43.20%	+10.24%
CNXU Conexeu Sciences	-5.04%	+38.17%	+1,599,999,900.00%	+1,599,999,900.00%	+1,599,999,900.00%
FONR Fonar	+0.04%	0.00%	+1.01%	+3.24%	+32.11%
KIDS OrthoPediatrics	+6.97%	+1.63%	+6.22%	+0.28%	-10.04%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$12.89 -10.0%	$11.04	$8.27 ▼ $30.10	$429.45M	1.31	683,065 shs	625,013 shs
CNXU Conexeu Sciences	$15.24 -4.8%	$0.00	$10.87 ▼ $18.79	$385.12M	N/A	103,889 shs	35,394 shs
FONR Fonar	$19.09	$18.83	$13.62 ▼ $19.16	$117.79M	0.95	140,673 shs	N/A
KIDS OrthoPediatrics	$18.32 +1.2%	$16.89	$14.42 ▼ $23.70	$464.90M	1.03	141,467 shs	83,242 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	+7.67%	+16.99%	+29.01%	+43.20%	+10.24%
CNXU Conexeu Sciences	-5.04%	+38.17%	+1,599,999,900.00%	+1,599,999,900.00%	+1,599,999,900.00%
FONR Fonar	+0.04%	0.00%	+1.01%	+3.24%	+32.11%
KIDS OrthoPediatrics	+6.97%	+1.63%	+6.22%	+0.28%	-10.04%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	2.33	Hold	$18.00	39.64% Upside
CNXU Conexeu Sciences	0.00	N/A	N/A	N/A
FONR Fonar	2.00	Hold	N/A	N/A
KIDS OrthoPediatrics	2.82	Moderate Buy	$24.44	33.43% Upside

Current Analyst Ratings Breakdown

Latest FONR, KIDS, CNXU, and CLPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/8/2026	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$16.00
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
4/21/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
4/20/2026	CLPT ClearPoint Neuro	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
4/7/2026	FONR Fonar	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
3/18/2026	CLPT ClearPoint Neuro	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$18.00 ➝ $20.00
3/5/2026	CLPT ClearPoint Neuro	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$28.00 ➝ $18.00

(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$36.97M	10.46	N/A	N/A	$0.99 per share	13.02
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
FONR Fonar	$104.35M	1.13	$2.10 per share	9.09	$25.81 per share	0.74
KIDS OrthoPediatrics	$236.35M	1.99	$0.17 per share	108.85	$13.82 per share	1.33

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$25.54M	-$1.01	N/A	N/A	N/A	-71.57%	-140.96%	-36.98%	8/11/2026 (Estimated)
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FONR Fonar	$8.33M	$1.00	19.09	N/A	N/A	6.35%	4.12%	3.07%	N/A
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	8/4/2026 (Estimated)

Latest FONR, KIDS, CNXU, and CLPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2026	Q1 2026	CLPT ClearPoint Neuro	-$0.28	-$0.32	-$0.04	-$0.32	$11.97 million	$12.13 million
5/11/2026	Q3 2026	FONR Fonar	N/A	$0.24	N/A	$0.24	N/A	$26.47 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million
3/17/2026	Q4 2025	CLPT ClearPoint Neuro	-$0.22	-$0.27	-$0.05	-$0.27	$10.40 million	$10.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
FONR Fonar	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	2.63	5.79	4.88
CNXU Conexeu Sciences	N/A	N/A	N/A
FONR Fonar	N/A	9.18	9.00
KIDS OrthoPediatrics	0.29	5.21	2.37

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
CNXU Conexeu Sciences	N/A
FONR Fonar	50.64%
KIDS OrthoPediatrics	69.05%

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.94%
CNXU Conexeu Sciences	N/A
FONR Fonar	7.93%
KIDS OrthoPediatrics	32.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	110	29.99 million	27.91 million	Optionable
CNXU Conexeu Sciences	4	25.27 million	N/A	N/A
FONR Fonar	480	6.17 million	5.68 million	Not Optionable
KIDS OrthoPediatrics	200	25.68 million	17.29 million	Optionable

FONR, KIDS, CNXU, and CLPT Headlines

Recent News About These Companies

A Look at OrthoPediatrics Corp (KIDS) After 4.1% Decline -- GF Value $33.82 vs Price $17.17

May 29, 2026 | gurufocus.com

OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 26, 2026 | globenewswire.com

How The OrthoPediatrics (KIDS) Story Is Shifting As Analysts Reassess Growth And Valuation

May 25, 2026 | finance.yahoo.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of "Moderate Buy" by Brokerages

May 18, 2026 | marketbeat.com

Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?

May 13, 2026 | insidermonkey.com

Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?

May 13, 2026 | finance.yahoo.com

Canaccord Genuity Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

May 6, 2026 | theglobeandmail.com

OrthoPediatrics raises 2026 revenue outlook to $263M-$267M while targeting free cash flow breakeven

May 1, 2026 | seekingalpha.com

OrthoPediatrics Corp (KIDS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...

May 1, 2026 | finance.yahoo.com

OrthoPediatrics (KIDS) Q1 2026 Earnings Transcript

May 1, 2026 | finance.yahoo.com

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

April 30, 2026 | seekingalpha.com

OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say

April 30, 2026 | zacks.com

OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates

April 30, 2026 | zacks.com

OrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance

April 30, 2026 | globenewswire.com

OrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System

April 30, 2026 | globenewswire.com

OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026

April 16, 2026 | globenewswire.com

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

March 31, 2026 | globenewswire.com

OrthoPediatrics Earnings Call Flags Profitable Turn

March 24, 2026 | theglobeandmail.com

Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know

March 24, 2026 | zacks.com

OrthoPediatrics (NASDAQ:KIDS) Insider Sells $145,469.25 in Stock

March 18, 2026 | insidertrades.com

OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?

March 3, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

FONR, KIDS, CNXU, and CLPT Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$12.89 -1.43 (-9.99%)

Closing price 04:00 PM Eastern

Extended Trading

$12.80 -0.09 (-0.67%)

As of 07:55 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Conexeu Sciences NASDAQ:CNXU

$15.24 -0.76 (-4.75%)

Closing price 03:58 PM Eastern

Extended Trading

$15.00 -0.24 (-1.57%)

As of 07:39 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Fonar NASDAQ:FONR

$19.09 0.00 (0.00%)

As of 06/4/2026

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

OrthoPediatrics NASDAQ:KIDS

$18.32 +0.22 (+1.22%)

Closing price 04:00 PM Eastern

Extended Trading

$18.34 +0.02 (+0.11%)

As of 05:55 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FONR, KIDS, CNXU, and CLPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FONR, KIDS, CNXU, and CLPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FONR, KIDS, CNXU, and CLPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

FONR, KIDS, CNXU, and CLPT Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

Conexeu Sciences NASDAQ:CNXU

Fonar NASDAQ:FONR

OrthoPediatrics NASDAQ:KIDS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FONR, KIDS, CNXU, and CLPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FONR, KIDS, CNXU, and CLPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FONR, KIDS, CNXU, and CLPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

FONR, KIDS, CNXU, and CLPT Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

Conexeu Sciences NASDAQ:CNXU

Fonar NASDAQ:FONR

OrthoPediatrics NASDAQ:KIDS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools